Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS
Oncology Reports · 2023
DOI: 10.3892/or.2023.8676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Tomoyuki Nanamiya und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108‑8639, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Oncolytic Viruses, Nectins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108‑8639, Japan.
- Division of Virus Engineering, Institute of Industrial Science, The University of Tokyo, Tokyo 153‑8505, Japan.
- Division of Virological Medicine, Institute of Industrial Science, The University of Tokyo, Tokyo 153‑8505, Japan.
- Division of Infectious Disease Control Science, Institute of Industrial Science, The University of Tokyo, Tokyo 153‑8505, Japan.
Zitieren
APA
Nanamiya, T., Takane, K., Yamaguchi, K., Okawara, Y., Arakawa, M., Saku, A., Ikenoue, T., Fujiyuki, T., Yoneda, M., Kai, C., & Furukawa, Y. (2023). Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. Oncology Reports. https://doi.org/10.3892/or.2023.8676
Vancouver
Nanamiya T, Takane K, Yamaguchi K, Okawara Y, Arakawa M, Saku A, et al. Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. Oncology Reports. 2023. doi:10.3892/or.2023.8676
BibTeX
@article{Nanamiya2023,
author = {Nanamiya, Tomoyuki and Takane, Kiyoko and Yamaguchi, Kiyoshi and Okawara, Yuya and Arakawa, Mariko and Saku, Akari and Ikenoue, Tsuneo and Fujiyuki, Tomoko and Yoneda, Misako and Kai, Chieko and Furukawa, Yoichi},
title = {Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS},
journal = {Oncology Reports},
year = {2023},
doi = {10.3892/or.2023.8676}
}
EUVIMED